What's new?

Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-Stage Healthcare VC Fund in Europe

European venture capital firm has raised €1 billion in the last 12 months across its expanding life science investment platform PARIS, France – October 19,¬ 2021 - Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today the close of its latest earl...

Inventiva’s lanifibranor meets the primary and key secondary endpoints in the Phase IIb NATIVE clinical trial in non-alcoholic steatohepatitis (NASH)

Daix (France), June 15, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced positive toplin...

Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board

Company announces strategic collaboration with SR-Tiget   MILAN, Italy – June 15, 2020   Epsilen Bio, a biotechnology company developing transformative therapies for patients affected by underserved medical conditions through stable epigenetic silencing of genes involved in pathological processes, announced today t...

Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation

June 11, 2020 05:10 AM Eastern Daylight Time LONDON--(BUSINESS WIRE)--Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group (SIX Swiss Exchange: TECN) announce a partnership to deepen the integration betwe...

AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products

Paris, Thursday June 11th 2020   Highlights   • €20 million European grant of private-public partnership “Bio Based Industry Joint Undertaking” • Construction of first flagship biorefinery confirmed through its affiliate AFYREN NEOXY • 50+ direct jobs in Northeast France and up to 200 indirect jobs expected   AFYRE...

Protera Closes $5.6M Series A Financing led by Sofinnova Partners

Startup to use funds to advance its AI-driven design and commercialization of new proteins to enable sustainable solutions   SANTIAGO, Chile and PARIS, France – June 10, 2020    Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced...

Biotalys Expands Executive Team and Establishes U.S. Headquarters to Strengthen North American Presence

Appoints Diego Angelo as Chief Business Officer and Head of Biotalys, Inc. to prepare for biofungicide launch GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., June 09, 2020 (GLOBE NEWSWIRE) -- Biotalys NV, a transformative food and crop protection company, today announced the expansion of its executive team and est...

Mainstay Medical Announces Reimbursement Approval for ReActiv8 in Australia

June 08, 2020 02:15 AM Eastern Daylight Time DUBLIN--(BUSINESS WIRE) Mainstay Medical Holdings plc (“Mainstay” or the “Company”), today announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved for inclusion in the Prostheses List of rei...

Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy

Centers for Medicare & Medicaid Services Issues New Codes for Peripheral Intravascular Lithotripsy Performed in Hospital Outpatient and Inpatient Settings   SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE)    Shockwave Medical, Inc (Nasdaq: SWAV), a pioneer in the development and commercialization of Intrava...

Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States

STOCKHOLM, June 5, 2020/PRNewswire/    Calliditas Therapeutics AB (publ) ("Calliditas") announced today the pricing of its initial public offering on The Nasdaq Global Select Market by way of a capital increase of 9,230,770 new common shares, consisting of a public offering of 8,306,770 common shares in the form of...

NodThera Announces Close of $55 Million Series B Financing

Financing round led by Novo Ventures and includes new investors Cowen Healthcare Investments and Sanofi Ventures, as well as existing investors 5AM Ventures, F-Prime Capital, Sofinnova Partners and founding investor Epidarex Capital   Proceeds to support advancement of pipeline of small molecule NLRP3 inflammasome ...

1 ... 8 9 10 11